Literature DB >> 20623219

Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse.

S Muñoz1, S Franckhauser, I Elias, T Ferré, A Hidalgo, A M Monteys, M Molas, S Cerdán, A Pujol, J Ruberte, F Bosch.   

Abstract

AIMS/HYPOTHESIS: In adipocytes, triacylglycerol synthesis depends on the formation of glycerol 3-phosphate, which originates either from glucose, through glycolysis, or from lactate, through glyceroneogenesis. However, glucose is traditionally viewed as the main precursor of the glycerol backbone and thus, enhanced glucose uptake would be expected to result in increased triacylglycerol synthesis and contribute to obesity.
METHODS: To further explore this issue, we generated a mouse model with chronically increased glucose uptake in adipose tissue by expressing Gck, which encodes the glucokinase enzyme.
RESULTS: Here we show that the production of high levels of glucokinase led to increased adipose tissue glucose uptake and lactate production, improved glucose tolerance and higher whole-body and skeletal muscle insulin sensitivity. There was no parallel increase in glycerol 3-phosphate synthesis in vivo, fat accumulation or obesity. Moreover, at high glucose concentrations, in cultured fat cells overproducing glucokinase, glycerol 3-phosphate synthesis from pyruvate decreased, while glyceroneogenesis increased in fat cells overproducing hexokinase II. CONCLUSIONS/INTERPRETATIONS: These findings indicate that the absence of glucokinase inhibition by glucose 6-phosphate probably led to increased glycolysis and blocked glyceroneogenesis in the mouse model. Furthermore, this study suggests that under physiological conditions, when blood glucose increases, glyceroneogenesis may prevail over glycolysis for triacylglycerol formation because of the inhibition of hexokinase II by glucose 6-phosphate. Together these results point to the indirect pathway (glucose to lactate to glycerol 3-phosphate) being key for fat deposition in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623219     DOI: 10.1007/s00125-010-1840-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver.

Authors:  L Reshef; R W Hanson; F J Ballard
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

2.  Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue.

Authors:  F J Ballard; R W Hanson; G A Leveille
Journal:  J Biol Chem       Date:  1967-06-10       Impact factor: 5.157

Review 3.  Lactate production in adipose tissue: a regulated function with extra-adipose implications.

Authors:  M DiGirolamo; F D Newby; J Lovejoy
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

4.  Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver.

Authors:  T Ferre; E Riu; F Bosch; A Valera
Journal:  FASEB J       Date:  1996-08       Impact factor: 5.191

5.  Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia.

Authors:  P J Otaegui; T Ferre; A Pujol; E Riu; R Jimenez; F Bosch
Journal:  Hum Gene Ther       Date:  2000-07-20       Impact factor: 5.695

6.  Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity.

Authors:  Sylvie Franckhauser; Sergio Muñoz; Ivet Elias; Tura Ferre; Fatima Bosch
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

Review 7.  Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning.

Authors:  L Gnudi; P R Shepherd; B B Kahn
Journal:  Proc Nutr Soc       Date:  1996-03       Impact factor: 6.297

8.  Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle.

Authors:  J M Ren; B A Marshall; E A Gulve; J Gao; D W Johnson; J O Holloszy; M Mueckler
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

9.  Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice.

Authors:  S Franckhauser; I Elias; V Rotter Sopasakis; T Ferré; I Nagaev; C X Andersson; J Agudo; J Ruberte; F Bosch; U Smith
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

10.  Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2.

Authors:  Yoo-Kyung Koh; Min-Young Lee; Jae-Woo Kim; Minji Kim; Jong-Seok Moon; Yoo-Jung Lee; Yong-Ho Ahn; Kyung-Sup Kim
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

View more
  23 in total

1.  Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice.

Authors:  Samantha L Hocking; Rebecca L Stewart; Amanda E Brandon; Eurwin Suryana; Ella Stuart; Emily M Baldwin; Ganesh A Kolumam; Zora Modrusan; Jagath R Junutula; Jenny E Gunton; Michael Medynskyj; Sinead P Blaber; Elisabeth Karsten; Benjamin R Herbert; David E James; Gregory J Cooney; Michael M Swarbrick
Journal:  Diabetologia       Date:  2015-04-22       Impact factor: 10.122

2.  Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice.

Authors:  G A Raciti; T K Bera; O Gavrilova; I Pastan
Journal:  Diabetologia       Date:  2011-08-13       Impact factor: 10.122

3.  Overexpressing the hydroxycarboxylic acid receptor 1 in mouse brown adipose tissue restores glucose tolerance and insulin sensitivity in diet-induced obese mice.

Authors:  Hyeon-Young Min; Jiyeon Hwang; Yuna Choi; Young-Hwan Jo
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-13       Impact factor: 5.900

4.  Nitrite augments glucose uptake in adipocytes through the protein kinase A-dependent stimulation of mitochondrial fusion.

Authors:  Nicholas K H Khoo; Li Mo; Sergey Zharikov; Christelle Kamga-Pride; Kelly Quesnelle; Franca Golin-Bisello; Lihua Li; Yinna Wang; Sruti Shiva
Journal:  Free Radic Biol Med       Date:  2014-02-17       Impact factor: 7.376

5.  Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance.

Authors:  Ivet Elias; Sylvie Franckhauser; Tura Ferré; Laia Vilà; Sabrina Tafuro; Sergio Muñoz; Carles Roca; David Ramos; Anna Pujol; Efren Riu; Jesús Ruberte; Fatima Bosch
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

6.  Adipocyte pyruvate dehydrogenase kinase 4 expression is associated with augmented PPARγ upregulation in early-life programming of later obesity.

Authors:  Mark J Holness; Gulrez Zariwala; Celia G Walker; Mary C Sugden
Journal:  FEBS Open Bio       Date:  2012-03-05       Impact factor: 2.693

7.  Utilization of dietary glucose in the metabolic syndrome.

Authors:  Marià Alemany
Journal:  Nutr Metab (Lond)       Date:  2011-10-26       Impact factor: 4.169

8.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

9.  BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice.

Authors:  Estefania Casana; Veronica Jimenez; Victor Sacristan; Sergio Muñoz; Claudia Jambrina; Jordi Rodó; Miquel Garcia; Cristina Mallol; Xavier León; Sylvie Franckhauser; Fatima Bosch
Journal:  Int J Obes (Lond)       Date:  2020-10-27       Impact factor: 5.095

10.  Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy.

Authors:  David Callejas; Christopher J Mann; Eduard Ayuso; Ricardo Lage; Iris Grifoll; Carles Roca; Anna Andaluz; Rafael Ruiz-de Gopegui; Joel Montané; Sergio Muñoz; Tura Ferre; Virginia Haurigot; Shangzhen Zhou; Jesús Ruberte; Federico Mingozzi; Katherine A High; Felix Garcia; Fatima Bosch
Journal:  Diabetes       Date:  2013-02-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.